Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Settlement, a potential problem.

Is it possible that the J3 is breaking the patents down into 336, 584 etc, and saying that only TPL should be paid for the 584 and only PTSC should be paid for the 336?

Milestone, what do you think their gameplan is?

Share
New Message
Please login to post a reply